Found 3 hits for monomerid = 50281775 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50281775
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells |
Bioorg Med Chem Lett 3: 937-942 (1993)
Article DOI: 10.1016/S0960-894X(00)80696-4 BindingDB Entry DOI: 10.7270/Q2H9954N |
More data for this Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50281775
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells |
Bioorg Med Chem Lett 3: 937-942 (1993)
Article DOI: 10.1016/S0960-894X(00)80696-4 BindingDB Entry DOI: 10.7270/Q2H9954N |
More data for this Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50281775
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells |
Bioorg Med Chem Lett 3: 937-942 (1993)
Article DOI: 10.1016/S0960-894X(00)80696-4 BindingDB Entry DOI: 10.7270/Q2H9954N |
More data for this Ligand-Target Pair | |